Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
Myhre syndrome
Other Resources UpToDate PubMed

Myhre syndrome

Contributors: John F. Cox III MD, FACP, Elizabeth M. Cox MD, Eric Ingerowski MD, FAAP
Other Resources UpToDate PubMed

Synopsis

Myhre syndrome is a rare genetic connective tissue disorder with multisystem involvement. One of at least four known mutations in the SMAD4 gene replaces an amino acid at protein position 496 or 500 with a different amino acid. Studies suggest that these mutations result in an abnormally stable SMAD4 protein that remains active in the cell longer than needed, enhancing the activity of the SMAD4 protein, which may result in abnormal transforming growth factor beta (TGF-β) signaling in many cell types, affecting development of several parts of the body.

Associated restrictive cardiomyopathy can be rapidly progressive. Laryngotracheal stenosis can cause life-threatening complications. The risk appears to increase with age and usually presents in adolescence or young adulthood.

Codes

ICD10CM:
Q87.89 – Other specified congenital malformation syndromes, not elsewhere classified

SNOMEDCT:
699316006 – Myhre syndrome

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:11/15/2021
Last Updated:01/19/2022
Copyright © 2024 VisualDx®. All rights reserved.
Myhre syndrome
Print  
A medical illustration showing key findings of Myhre syndrome
Copyright © 2024 VisualDx®. All rights reserved.